Clinical Trial Update: Low-dose Radioiodine Ablation in Graves' Disease

View source ↗

Summary

A completed clinical trial update evaluating low-dose radioiodine ablation for Graves' disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• Radioactive iodine therapy (Iodine-131) (Iodine-131)

Snippet

Sponsor: University of Pisa | Conditions: Thyroid Diseases | Status: COMPLETED